Guangzhou Baiy traded at 19.88 this Thursday September 10th, decreasing 0.31 or 1.54 percent since the previous trading session. Looking back, over the last four weeks, Guangzhou Baiy lost 7.66 percent. Over the last 12 months, its price fell by 25.26 percent. Looking ahead, we forecast Guangzhou Baiy to be priced at 19.75 by the end of this quarter and at 18.34 in one year, according to Trading Economics global macro models projections and analysts expectations.
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd i is engaged in the pharmaceutical and healthcare industry. The Company's segments are Great Southern TCM, Great Commerce, Great Health and Great Medical Care. The Company's Great South TCM includes research, development, manufacturing and sales for Chinese and western medicine, chemical raw medicine, natural drug, biological medicine and intermediates of chemical raw medicine. The Company's Great Health segment includes the research, development, manufacturing and sales of beverages, foods, health products and other products. The Company's Great Commerce segment includes wholesale, retail, import and export for western medicine, Chinese medicine and medical apparatus and instruments. The Great Medical segment is engaged in medical services, traditional Chinese medicine health preservation, modern pension and medical equipment industry.